Comparison of Six Commercial Diagnostic Tests for the Detection of Dengue Virus Non-Structural-1 Antigen and IgM/IgG Antibodies
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
ELISAs and rapid diagnostic tests (RDTs) are widely used for diagnosing dengue virus (DENV) infection. Using 138 single blood samples, we compared the ability to detect non-structural (NS)-1 antigen and anti-DENV IgM/IgG antibodies among (1) DENV Detect NS1 ELISA, DENV Detect IgM capture ELISA and DENV Detect IgG ELISA (InBios International, Inc.); (2) Anti-Dengue virus IgM Human ELISA and Anti-Dengue virus IgG Human ELISA (Abcam); (3) Dengue virus NS1 ELISA, Anti-Dengue virus ELISA (IgM) and Anti-Dengue virus ELISA (IgG) (Euroimmun); (4) Asan Easy Test Dengue NS1 Ag 100 and Asan Easy Test Dengue IgG/IgM (Asan Pharm); (5) SD BIOLINE Dengue Duo (Standard Diagnostics); and (6) Ichroma Dengue NS1 and Ichroma Dengue IgG/IgM (Boditech Med). For NS1 antigen detection, InBios and Euroimmun showed higher sensitivities (100%) than the RDTs (42.9–64.3%). All tests demonstrated variable sensitivities for IgM (38.1–90.5%) and IgG (65.7–100.0%). InBios and Boditech Med demonstrated higher sensitivity (95.6% and 88.2%, respectively) than the other tests for combined NS1 antigen and IgM antibody. Five NS1 antigen tests had good agreement (92.8–98.6%) without showing positivity for chikungunya. However, all IgG tests demonstrated potential false-positivity with variable ranges. Clinical laboratories should note performance variations across tests and potential cross-reactivity.
Abstract
ELISAs and rapid diagnostic tests (RDTs) are widely used for diagnosing dengue virus (DENV) infection. Using 138 single blood samples, we compared the ability to detect non-structural (NS)-1 antigen and anti-DENV IgM/IgG antibodies among (1) DENV Detect NS1 ELISA, DENV Detect IgM capture ELISA and DENV Detect IgG ELISA (InBios International, Inc.); (2) Anti-Dengue virus IgM Human ELISA and Anti-Dengue virus IgG Human ELISA (Abcam); (3) Dengue virus NS1 ELISA, Anti-Dengue virus ELISA (IgM) and Anti-Dengue virus ELISA (IgG) (Euroimmun); (4) Asan Easy Test Dengue NS1 Ag 100 and Asan Easy Test Dengue IgG/IgM (Asan Pharm); (5) SD BIOLINE Dengue Duo (Standard Diagnostics); and (6) Ichroma Dengue NS1 and Ichroma Dengue IgG/IgM (Boditech Med). For NS1 antigen detection, InBios and Euroimmun showed higher sensitivities (100%) than the RDTs (42.9–64.3%). All tests demonstrated variable sensitivities for IgM (38.1–90.5%) and IgG (65.7–100.0%). InBios and Boditech Med demonstrated higher sensitivity (95.6% and 88.2%, respectively) than the other tests for combined NS1 antigen and IgM antibody. Five NS1 antigen tests had good agreement (92.8–98.6%) without showing positivity for chikungunya. However, all IgG tests demonstrated potential false-positivity with variable ranges. Clinical laboratories should note performance variations across tests and potential cross-reactivity.
참고문헌 (17)
- "Dengue guidelines for diagnosis, treatment, prevention and control: new edition" (2009)[URL]
- Muhammad Suleman, "Dengue Virus Serotypes Circulating in Khyber Pakhtunkhwa Province, Pakistan, 2013-2015", Annals of Laboratory Medicine, 37(2), pp.151~154 (2017), 대한진단검사의학회
- Blacksell SD, "Evaluation of six commercial point-of-care tests for diagnosis of acute dengue infections : the need for combining NS1 antigen and IgM", IgG antibody detection to achieve acceptable levels of accuracy, 2011, pp.18, 2095~2101
- Fatima A, "Review : progress in the diagnosis of dengue virus infections and importance of point of care test : a review", Pak J Pharm Sci, 28, pp.271~280 (2015)
- Dussart P, "Evaluation of an enzyme immunoassay for detection of dengue virus NS1 antigen in human serum", Clin Vaccine Immunol, 13, pp.1185~1189 (2006)
- Andries AC, "Evaluation of the performances of six commercial kits designed for dengue NS1 and anti-dengue IgM, IgG and IgA detection in urine and saliva clinical specimens", BMC Infect Dis, 16, pp.201~ (2016)
- Murugananthan K, "Comparison of a rapid immuno-chromatography assay with a standard ELISA for the detection of IgM and IgG antibodies against dengue viruses", Virusdisease, 29, pp.199~202 (2018)
- Blacksell SD, "Comparison of seven commercial antigen and antibody enzyme-linked immunosorbent assays for detection of acute dengue infection", Clin Vaccine Immunol, 19, pp.804~810 (2012)
- Pang J, "Progress and challenges towards point-of-care diagnostic development for dengue", J Clin Microbiol, 55, pp.3339~3349 (2017)
- Vickers IE, "The performance of the SD BIOLINE Dengue DUO® rapid immunochromatographic test kit for the detection of NS1 antigen, IgM and IgG antibodies during a dengue type 1 epidemic in Jamaica", J Biomed Sci, 22, pp.55~ (2015)
- Vickers I, "Evaluation of OneStep Dengue NS1 RapiDip™ InstaTest and OneStep Dengue Fever IgG", IgM RapiCard™ InstaTest during the course of a dengue type 1 epidemic, 2017, pp.89, 271~275
- Hunsperger EA, "Evaluation of commercially available diagnostic tests for the detection of dengue virus NS1 antigen and anti-dengue virus IgM antibody", PLoS Negl Trop Dis, 8, pp.e3171~ (2014)
- Anand AM, "Evaluation of NS1 antigen detection for early diagnosis of dengue in a tertiary hospital in Southern India", J Clin Diagn Res, 10, pp.DC01~DC04 (2016)
- Allwinn R, "Cross-reactivity in flavivirus serology : new implications of an old finding", Med Microbiol Immunol, 190, pp.199~202 (2002)
- Hunsperger EA, "Evaluation of commercially available anti-dengue virus immunoglobulin M tests", Emerg Infect Dis, 15, pp.436~440 (2009)
- Hage DS, "Development of immunochromatographic assays for the selective detection of zika virus or dengue virus serotypes in serum", Clin Chem, 64, pp.991~993 (2018)
- Park JH, "Dengue fever in South Korea, 2006-2010", Emerg Infect Dis, 18, pp.1525~1527 (2012)